A Retrospective Study Evaluating the Use of Permacol Surgical Implant in the Repair of Abdominal Wall Defects

This study has been completed.
Information provided by (Responsible Party):
Medtronic - MITG
ClinicalTrials.gov Identifier:
First received: September 30, 2010
Last updated: April 8, 2014
Last verified: April 2014
To evaluate short, mid and long term clinical outcomes associated with the use of Permacol in the treatment of abdominal wall defects.

Condition Intervention
Abdominal Wall Defects
Device: Permacol Surgical Implant

Study Type: Observational
Study Design: Time Perspective: Retrospective

Resource links provided by NLM:

Further study details as provided by Medtronic - MITG:

Primary Outcome Measures:
  • Confirmed Hernia Recurrence [ Time Frame: 12 months ] [ Designated as safety issue: Yes ]
    Confirmed hernia or hernia recurrence: Proportion of patients treated with Permacol Surgical Implant who experienced hernia or hernia recurrence at the repair site. Hernia or recurrence is defined by hernia diagnosis during clinical assessment by surgeon or medical chart review

Secondary Outcome Measures:
  • Total Unconfirmed Hernia or Hernia Recurrence [ Time Frame: 12 Months ] [ Designated as safety issue: Yes ]

    Total unconfirmed hernia or hernia recurrence at the repair site by year (Number and percentage)

    Unconfirmed hernia or recurrence reported by the subject is defined by confirmation of hernia symptoms based on results of the Symptoms Questionniare but not confirmed by clinical assessment by a surgeon or medical chart review

  • Hernia or Hernia Recurrence by Year From Year 2 to Last Year Observed [ Time Frame: Year 2 to Year 8 ] [ Designated as safety issue: Yes ]
    Confirmed and Unconfirmed hernia or hernia recurrence by year from Year 2 to last year observed

Enrollment: 343
Study Start Date: October 2010
Study Completion Date: January 2012
Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Permacol Patients
Patients who have undergone surgical repair of their abdominal wall defect with Permacol Surgical Implants with at least 12 months follow up.
Device: Permacol Surgical Implant
Permacol Surgical Implant


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients who have undergone surgical repair of their abdominal wall defects with Permacol Surgical Implants with at least 12 months(-30days)follow-up

Inclusion Criteria:

  • Equal or over 18 years of age
  • Had undergone surgical repair or reconstruction of abdominal wall defects, ventral hernias or incisional hernias using Permacol Surgical Implant.
  • At least 12 months of follow-up post date of surgery (-30 days)
  • Undergone open or laparoscopic repairs

Exclusion Criteria:

  • Had undergone inguinal, parastomal, diaphragmatic or paraesophageal/hiatal hernia repair
  • Any prior use of Permacol in abdominal wall repair
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01214252

United States, Massachusetts
Annie Choi
Bedford, Massachusetts, United States, 01730
Sponsors and Collaborators
Medtronic - MITG
  More Information

No publications provided by Medtronic - MITG

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Medtronic - MITG
ClinicalTrials.gov Identifier: NCT01214252     History of Changes
Other Study ID Numbers: COVPERH0046 
Study First Received: September 30, 2010
Results First Received: June 21, 2012
Last Updated: April 8, 2014
Health Authority: United States: Institutional Review Board
European Union: European Medicines Agency
National Competent Authorities (NCAs) of EU Member states: UK

Keywords provided by Medtronic - MITG:
Repair of patients' abdominal wall defects

ClinicalTrials.gov processed this record on February 04, 2016